WO2022088511A1 - Reagent for lysing virus sample - Google Patents

Reagent for lysing virus sample Download PDF

Info

Publication number
WO2022088511A1
WO2022088511A1 PCT/CN2021/071117 CN2021071117W WO2022088511A1 WO 2022088511 A1 WO2022088511 A1 WO 2022088511A1 CN 2021071117 W CN2021071117 W CN 2021071117W WO 2022088511 A1 WO2022088511 A1 WO 2022088511A1
Authority
WO
WIPO (PCT)
Prior art keywords
reagent
virus
sample
titanium dioxide
formula
Prior art date
Application number
PCT/CN2021/071117
Other languages
French (fr)
Chinese (zh)
Inventor
张敏
杨蓉
张权峰
宋学文
叶凯璐
周康
Original Assignee
杭州微策生物技术股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 杭州微策生物技术股份有限公司 filed Critical 杭州微策生物技术股份有限公司
Publication of WO2022088511A1 publication Critical patent/WO2022088511A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/165Coronaviridae, e.g. avian infectious bronchitis virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the invention belongs to the field of disease diagnosis, and relates to a reagent for splitting virus samples, in particular to a reagent for splitting novel coronavirus samples.
  • the general immunochromatographic detection test paper includes a support layer, a sample pad, a marker pad, a reaction area, and an absorbent paper.
  • the sample pad, the marker pad, the reaction area, and the absorbent paper are overlapped on the support layer in turn, and the reaction area includes the quality control line (C line ) and the detection line (T line), when a certain amount of the sample to be tested is applied to the sample pad, due to capillary action, after being evenly dispersed through the sample pad, after the marking of the marking pad, in the reaction area, it is respectively connected with the C line and the C line of the reaction area.
  • the antigen or antibody on the T line reacts, and the remaining liquid after the reaction is absorbed by the absorbent paper.
  • the C line signal value tends to be stable, the result of the reaction with the antigen or antibody shows the strength of the T line signal value.
  • lysis When conducting virus detection, such as new coronavirus detection, it is necessary to lyse the collected samples on the nasal swab or throat swab to obtain the sample to be tested, and then apply it to the fluorescent immunochromatography test paper for reaction, lysis
  • the lysis effect of the solution on the component to be tested (virus) in the sample is directly reflected in the strength of the T-line signal value, so the formulation of the lysis solution is particularly important. Due to the poor lysis effect of the existing virus lysate, the detection sensitivity of the virus is affected, especially when the virus content is particularly low, it is very easy to cause false detection and missed detection.
  • the present invention provides a new lysis solution formulation, which contains nano-titanium dioxide, which can significantly improve the lysis effect of the components to be tested in the sample, thereby greatly improving the virus detection sensitivity, especially for novel The lysis of the coronavirus.
  • the present invention provides a virus-splitting reagent, comprising titanium dioxide, buffer, surfactant and preservative.
  • titanium dioxide is nano titanium dioxide.
  • the content of the nano titanium dioxide is 0.01%-0.1%.
  • the buffer solution includes sodium chloride, phosphate and sodium caseinate.
  • the buffer solution includes sodium chloride 0.15-0.45 mol/L, phosphate 1.15-2.9 g/L, and sodium caseinate content of 0.5%.
  • the surfactant is Triton X-100.
  • the preservative is Proclin 300.
  • the present invention also provides a fluorescence immunochromatography detection kit, which is characterized in that it includes the virus splitting reagent according to any one of claims 1 to 7, and an immune layer for detecting virus antigens Analysis test paper.
  • the present invention provides the use of nano-titanium dioxide for preparing a reagent for splitting virus samples.
  • virus sample is a novel coronavirus sample.
  • the beneficial effect of the present invention is that the virus can be better split through the splitting of the present invention, and more antigens or antigenic sites can be exposed, thereby improving the detection sensitivity.
  • the amount of virus in the sample is particularly low, it is hoped that a positive result can be obtained, and more antigen fragments or virus fragments are expected to be obtained.
  • the lysis solution provided by the present invention to lyse the sample can significantly increase the virus antigen concentration in the sample. Therefore, the immunofluorescence test strip is used to increase the minimum threshold of detection and prevent missed detection.
  • Fig. 1 is the T-line mean value level comparison diagram obtained for lysate formulations 1-6 in Example 8
  • the positive samples in the following examples are virus cultures with a virus titer of 1.51 ⁇ 10 6 TCID 50 /mL, diluted to 15,000 times, 10,000 times, 5,000 times, and 1,000 times, respectively, as samples to be tested.
  • a virus titer 1.51 ⁇ 10 6 TCID 50 /mL, diluted to 15,000 times, 10,000 times, 5,000 times, and 1,000 times, respectively, as samples to be tested.
  • the T line signal value is similar to the background value, and it is judged as negative.
  • the background value refers to the signal value detected when no sample is injected.
  • the preparation method of the fluorescence immunochromatography detection test paper used in the present invention is as follows, and the fluorescence immunochromatography detection test paper used in the present invention is the test paper produced in the same batch:
  • Step 1 Fluorescent microspheres are labeled with monoclonal antibody against NP protein of novel coronavirus.
  • sample pad treatment solution 0.01M pH 7.4 phosphate buffered saline solution, fixed mass fraction of BSA, surfactant, PVP K30.
  • Step 4 Dilute and spray the antibody marker
  • step 1 The novel coronavirus NP protein monoclonal antibody labeled with fluorescent microspheres in step 1 was sprayed on the glass fiber treated in step 3 at a speed of 3.0uL/cm with a gold sprayer, and placed in a drying oven at 37°C overnight. Dry, take out and place in an aluminum foil bag and seal it for later use;
  • Step 5 Scribing the nitrocellulose membrane
  • Embodiment 2 Lysis solution formula 1
  • Lysis solution 1 contains the following components by mass fraction: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.12g KH2PO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300.
  • the pH of the lysate was 8.0.
  • the new coronavirus positive culture concentration is 1/15000 of the original concentration
  • the T line has a signal
  • the line background signal that is, the T line signal when the culture concentration is When the result is negative.
  • the culture concentration was 1/10000, 1/5000 and 1/5000 of the original concentration, it was judged as a positive result.
  • Lysis solution 2 contains the following components in mass fractions: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300.
  • the pH of the lysate was 8.0.
  • Embodiment 4 Lysis solution formula 3
  • Lysis solution 3 contains the following components in mass fractions: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.12g KH2PO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.01% Nano Titanium Dioxide.
  • the pH of the lysate was 8.0.
  • Embodiment 5 Lysis solution formula 4
  • Lysis solution 4 contains the following components in mass fractions: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.02% nano-titanium dioxide.
  • the pH of the lysate was 8.0.
  • Embodiment 6 Lysis solution formula 5
  • Lysis solution 5 contains the following components in mass fractions: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.03% nano-titanium dioxide.
  • the pH of the lysate was 8.0.
  • Embodiment 7 Lysis solution formula 6
  • Lysis solution 6 contains the following components by mass fraction: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.05% nano-titanium dioxide.
  • the pH of the lysate was 8.0.

Abstract

The present invention provides a reagent for lysing a virus sample. The reagent contains nano titanium dioxide, such that a lysing effect on a component to be tested in the sample can be obviously improved, thereby greatly improving the virus test sensitivity, especially the lysing of SARS-CoV-2.

Description

一种用于裂解病毒样本的试剂A reagent for splitting virus samples 技术领域technical field
本发明属于疾病诊断领域,涉及一种用于裂解病毒样本的试剂,尤其涉及一种用于裂解新型冠状病毒样本的试剂。The invention belongs to the field of disease diagnosis, and relates to a reagent for splitting virus samples, in particular to a reagent for splitting novel coronavirus samples.
背景技术Background technique
免疫层析技术(ImmunochromatographicAssay,ICA)是20世纪末发展起来的结合免疫技术和色谱层析技术的一种分析方法,该方法具有特异性、操作简单、快速等特点,广泛应用于临床诊断、环境监测、食品安全等重要领域。一般免疫层析检测试纸包括支持层、样品垫、标记垫、反应区、吸水纸,样品垫、标记垫、反应区、吸水纸依次搭接在支持层上,反应区包括质控线(C线)和检测线(T线),当一定量的待检测样本被施加到样品垫上,由于毛细作用,通过样品垫分散均匀后,经过标记垫的标记,在反应区分别与反应区的C线和T线上的抗原或抗体进行反应,反应后剩余的液体被吸水纸吸收,当C线信号值趋于稳定时,与抗原或抗体反应的结果表现为T线信号值的强弱。Immunochromatographic Assay (ICA) is an analytical method developed at the end of the 20th century that combines immunological and chromatographic techniques. , food safety and other important areas. The general immunochromatographic detection test paper includes a support layer, a sample pad, a marker pad, a reaction area, and an absorbent paper. The sample pad, the marker pad, the reaction area, and the absorbent paper are overlapped on the support layer in turn, and the reaction area includes the quality control line (C line ) and the detection line (T line), when a certain amount of the sample to be tested is applied to the sample pad, due to capillary action, after being evenly dispersed through the sample pad, after the marking of the marking pad, in the reaction area, it is respectively connected with the C line and the C line of the reaction area. The antigen or antibody on the T line reacts, and the remaining liquid after the reaction is absorbed by the absorbent paper. When the C line signal value tends to be stable, the result of the reaction with the antigen or antibody shows the strength of the T line signal value.
在进行病毒检测时,例如新型冠状病毒检测时,需要对采集到的鼻拭子或者咽拭子上的样本进行裂解处理后得到待检测样本,再施加到荧光免疫层析试纸上进行反应,裂解液对样本中待测成分(病毒)的裂解效果的好坏直接反映在T线信号值的强弱,因此裂解液的配方尤为重要。现有病毒裂解液由于裂解效果不佳,从而影响病毒的检测灵敏度,尤其是在病毒含量特别低时,非常容易造成错检和漏检。When conducting virus detection, such as new coronavirus detection, it is necessary to lyse the collected samples on the nasal swab or throat swab to obtain the sample to be tested, and then apply it to the fluorescent immunochromatography test paper for reaction, lysis The lysis effect of the solution on the component to be tested (virus) in the sample is directly reflected in the strength of the T-line signal value, so the formulation of the lysis solution is particularly important. Due to the poor lysis effect of the existing virus lysate, the detection sensitivity of the virus is affected, especially when the virus content is particularly low, it is very easy to cause false detection and missed detection.
发明内容SUMMARY OF THE INVENTION
本发明针对现有技术的不足,提供了一种新的裂解液配方,该配方中含有纳米二氧化钛,可明显提高对样本中待测成分的裂解效果,从而大幅提高病毒检测灵敏度,特别是针对新型冠状病毒的裂解。Aiming at the deficiencies of the prior art, the present invention provides a new lysis solution formulation, which contains nano-titanium dioxide, which can significantly improve the lysis effect of the components to be tested in the sample, thereby greatly improving the virus detection sensitivity, especially for novel The lysis of the coronavirus.
本发明提供了一种裂解病毒的试剂,包括二氧化钛、缓冲液、表面活性剂和防腐剂。The present invention provides a virus-splitting reagent, comprising titanium dioxide, buffer, surfactant and preservative.
进一步地,所述二氧化钛为纳米二氧化钛。Further, the titanium dioxide is nano titanium dioxide.
进一步地,所述纳米二氧化钛的含量为0.01%-0.1%。Further, the content of the nano titanium dioxide is 0.01%-0.1%.
进一步地,所述的缓冲液包括氯化钠、磷酸盐和酪蛋白钠。Further, the buffer solution includes sodium chloride, phosphate and sodium caseinate.
进一步地,所述的缓冲液包括氯化钠0.15-0.45mol/L、磷酸盐1.15-2.9g/L、酪蛋白钠的含量为0.5%。Further, the buffer solution includes sodium chloride 0.15-0.45 mol/L, phosphate 1.15-2.9 g/L, and sodium caseinate content of 0.5%.
进一步地,所述表面活性剂为Triton X-100。Further, the surfactant is Triton X-100.
进一步地,所述防腐剂为Proclin 300。Further, the preservative is Proclin 300.
另一方面,本发明还提供了一种荧光免疫层析检测试剂盒,其特征在于,包括如权利要求1~7任一项所述的裂解病毒的试剂,和用于检测病毒抗原的免疫层析试纸。On the other hand, the present invention also provides a fluorescence immunochromatography detection kit, which is characterized in that it includes the virus splitting reagent according to any one of claims 1 to 7, and an immune layer for detecting virus antigens Analysis test paper.
在一方面,本发明提供了纳米二氧化钛用于制备裂解病毒样本的试剂上的用途。In one aspect, the present invention provides the use of nano-titanium dioxide for preparing a reagent for splitting virus samples.
进一步地,所述病毒样本为新型冠状病毒样本。Further, the virus sample is a novel coronavirus sample.
本发明的有益效果为,通过本发明的裂解可以更好的裂解病毒,暴露出更多的抗原或者抗原位点,从而提高检测的灵敏度。在样本中病毒量特别低的时候,希望能够获得阳性结果,就希望获得更多的抗原片段或者病毒片段,采用本发明提供的裂解液对样本进行裂解,可以明显提高样本中的病毒抗原浓度,从而采用免疫荧光测试条,提高检测的最低阀值,防止漏检。The beneficial effect of the present invention is that the virus can be better split through the splitting of the present invention, and more antigens or antigenic sites can be exposed, thereby improving the detection sensitivity. When the amount of virus in the sample is particularly low, it is hoped that a positive result can be obtained, and more antigen fragments or virus fragments are expected to be obtained. Using the lysis solution provided by the present invention to lyse the sample can significantly increase the virus antigen concentration in the sample. Therefore, the immunofluorescence test strip is used to increase the minimum threshold of detection and prevent missed detection.
附图说明Description of drawings
图1为实施例8中的针对裂解液配方1-6所得的T线均值水平对比图Fig. 1 is the T-line mean value level comparison diagram obtained for lysate formulations 1-6 in Example 8
具体实施方式Detailed ways
下面结合实施例对本发明作进一步详细描述,需要指出的是,以下所述实施例旨在便于对本发明的理解,而对其不起任何限定作用。本实施例中未特别指出的试剂均为已知产品,通过购买市售产品获得。The present invention will be described in further detail below with reference to the examples. It should be noted that the following examples are intended to facilitate the understanding of the present invention, but do not have any limiting effect on it. The reagents not specified in this example are all known products, obtained by purchasing commercially available products.
以下实施例中的阳性样本为使用病毒滴度为1.51×10 6TCID 50/mL的病毒培养物,分别稀释成1.5万倍、1万倍、5千倍、1千倍作为待测样本分别评估裂解液配方的裂解效果,在现有的裂解液体系中稀释倍数大于1万倍后,T线信号值表现为与本底值相近,判定为阴性。 The positive samples in the following examples are virus cultures with a virus titer of 1.51×10 6 TCID 50 /mL, diluted to 15,000 times, 10,000 times, 5,000 times, and 1,000 times, respectively, as samples to be tested. For the lysis effect of the lysis solution formula, after the dilution ratio in the existing lysis solution system is greater than 10,000 times, the T line signal value is similar to the background value, and it is judged as negative.
名词解释:本底值,是指没有进样时检测到的信号值。Explanation of terms: The background value refers to the signal value detected when no sample is injected.
实施例1:荧光免疫层析检测试纸Example 1: Fluorescence immunochromatography detection test paper
本发明所使用的荧光免疫层析检测试纸制作方法如下,本发明所使用的荧光免疫层析检测试纸为同批制作的试纸:The preparation method of the fluorescence immunochromatography detection test paper used in the present invention is as follows, and the fluorescence immunochromatography detection test paper used in the present invention is the test paper produced in the same batch:
步骤一:荧光微球标记新型冠状病毒NP蛋白单克隆抗体。Step 1: Fluorescent microspheres are labeled with monoclonal antibody against NP protein of novel coronavirus.
将荧光微球与新型冠状病毒NP蛋白单克隆抗体混匀反应,得到抗体标记物,用复溶液复溶。Mix the fluorescent microspheres with the monoclonal antibody of the novel coronavirus NP protein to obtain the antibody marker, which is reconstituted with the reconstituting solution.
步骤二:样本垫处理Step 2: Sample Pad Processing
(1)配置样本垫处理液:0.01M pH 7.4磷酸缓冲盐溶液,固定质量分数的BSA、表面活性剂、PVP K30。(1) Configure the sample pad treatment solution: 0.01M pH 7.4 phosphate buffered saline solution, fixed mass fraction of BSA, surfactant, PVP K30.
(2)将处理液均匀分散在玻璃纤维上,37℃干燥箱过夜干燥,取出置于铝箔袋内封口备用;(2) Disperse the treatment solution evenly on the glass fiber, dry it in a drying oven at 37°C overnight, take it out and place it in an aluminum foil bag and seal it for later use;
步骤三:结合垫处理Step 3: Bonding Pad Treatment
(1)配置结合垫处理液:0.02M pH 7.4磷酸缓冲溶液,固定质量分数的BSA、蔗糖、防腐剂。(1) Configure the binding pad treatment solution: 0.02M pH 7.4 phosphate buffer solution, fixed mass fraction of BSA, sucrose, and preservatives.
(2)将处理液均匀分散在玻璃纤维上,37℃干燥箱过夜干燥,取出置于铝箔袋内封口备用;(2) Disperse the treatment solution evenly on the glass fiber, dry it in a drying oven at 37°C overnight, take it out and place it in an aluminum foil bag and seal it for later use;
步骤四:抗体标记物稀释喷涂Step 4: Dilute and spray the antibody marker
(1)将步骤一荧光微球标记的新型冠状病毒NP蛋白单克隆抗体用划膜喷金仪以3.0uL/cm的速度喷涂在步骤三处理的的玻璃纤维上,置于37℃干燥箱过夜干燥,取出置于铝箔袋封口待用;(1) The novel coronavirus NP protein monoclonal antibody labeled with fluorescent microspheres in step 1 was sprayed on the glass fiber treated in step 3 at a speed of 3.0uL/cm with a gold sprayer, and placed in a drying oven at 37°C overnight. Dry, take out and place in an aluminum foil bag and seal it for later use;
步骤五:硝酸纤维素膜划膜Step 5: Scribing the nitrocellulose membrane
(1)将新型冠状病毒NP蛋白单克隆抗体用0.015M pH 7.4PBS稀释到一固定浓度,作为T线溶液;(1) Dilute the novel coronavirus NP protein monoclonal antibody to a fixed concentration with 0.015M pH 7.4PBS as a T-line solution;
(2)将山羊抗鼠多克隆抗体用0.015M pH 7.4PBS稀释到固定浓度,作为C线溶液;(2) Dilute the goat anti-mouse polyclonal antibody to a fixed concentration with 0.015M pH 7.4PBS as a C-line solution;
(3)用划膜喷金仪以1.0uL/cm的速度进行划膜,置于37℃干燥箱过夜干燥,取出置于铝箔袋封口待用;(3) Scribe the film at a speed of 1.0uL/cm with a film-scribing gold sprayer, place it in a drying oven at 37°C to dry overnight, take it out and place it in an aluminum foil bag and seal it for later use;
步骤六:组装切割与装袋Step 6: Assembly Cut and Bag
(1)将步骤二处理好的样本垫,步骤四喷涂好抗体标记物的结合垫,步骤五处理好的硝酸纤维素膜,吸水纸裁切为适当宽度,依次黏在底板上,每层之间搭牢1-2mm。(1) Cut the sample pad processed in step 2, the binding pad of the antibody marker by spraying in step 4, the nitrocellulose membrane processed in step 5, and the absorbent paper to an appropriate width, and stick them on the bottom plate in turn. 1-2mm between them.
(2)将粘好的大卡用斩切机斩切成4mm宽测试卡,装进检测装置中。(2) Cut the glued large card into 4mm wide test cards with a chopping machine, and put them into the detection device.
(3)装入铝箔袋中密封保存。(3) Put it in an aluminum foil bag and keep it sealed.
实施例2裂解液配方1Embodiment 2 Lysis solution formula 1
裂解液1含有如下质量分数的组分:0.15mol/L的NaCl,1.15g的Na2HPO4,0.12g的 KH2PO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300。所述裂解液的pH为8.0。Lysis solution 1 contains the following components by mass fraction: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.12g KH2PO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒阳性培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本50微升,15分钟后在荧光度数仪器中检测T线信号,记录并计算平均值,重复5次试验,所使用的测试条是实施例1中制备的测试条。Use this formula lysate to treat the new coronavirus-positive cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply 50 microliters of the sample to the fluorescence immunochromatography test paper. , 15 minutes later, the T-line signal was detected in the fluorescence meter, the average value was recorded and calculated, and the test was repeated 5 times. The test strip used was the test strip prepared in Example 1.
表1配方1检测结果Table 1 Test results of formula 1
Figure PCTCN2021071117-appb-000001
Figure PCTCN2021071117-appb-000001
从上表可以看出,在新型冠状病毒阳性培养物浓度为原浓度1/15000时,虽然T线有信号,但几乎与线本底信号,即培养物浓度为时的T线信号相似,这个时候,判断为阴性结果。而培养物浓度为原浓度的1/10000、1/5000和1/5000时,判断为阳性结果。As can be seen from the above table, when the new coronavirus positive culture concentration is 1/15000 of the original concentration, although the T line has a signal, it is almost similar to the line background signal, that is, the T line signal when the culture concentration is When the result is negative. On the other hand, when the culture concentration was 1/10000, 1/5000 and 1/5000 of the original concentration, it was judged as a positive result.
实施例3裂解液配方2Embodiment 3 Lysis solution formula 2
裂解液2含有如下质量分数的组分:0.15mol/L的NaCL,1.15g的Na2HPO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300。所述裂解液的pH为8.0。Lysis solution 2 contains the following components in mass fractions: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本,15分钟后检测T线信号,记录并计算平均值。Use the formula lysate to treat the new coronavirus cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply the sample on the fluorescence immunochromatography detection test paper. After 15 minutes T-line signal was detected, recorded and averaged.
表2配方2检测结果Table 2 formula 2 test results
Figure PCTCN2021071117-appb-000002
Figure PCTCN2021071117-appb-000002
从上表可以看出,虽然裂解液体发生改变,对于稀释相同的倍数,在培养物浓度为原浓度1/15000时,仍然不能检测到荧光信号,则结果仍然为阴性。As can be seen from the above table, although the lysing liquid has changed, for the same dilution, when the culture concentration is 1/15000 of the original concentration, the fluorescent signal cannot be detected, and the result is still negative.
实施例4裂解液配方3Embodiment 4 Lysis solution formula 3
裂解液3含有如下质量分数的组分:0.15mol/L的NaCl,1.15g的Na2HPO4,0.12g的KH2PO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300,0.01%的纳米二氧化钛。所述裂解液的pH为8.0。Lysis solution 3 contains the following components in mass fractions: 0.15mol/L NaCl, 1.15g Na2HPO4, 0.12g KH2PO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.01% Nano Titanium Dioxide. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本,15分钟后检测T线信号,记录并计算平均值。Use the formula lysate to treat the new coronavirus cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply the sample on the fluorescence immunochromatography detection test paper. After 15 minutes T-line signal was detected, recorded and averaged.
表3配方3的检测结果The detection result of table 3 formula 3
Figure PCTCN2021071117-appb-000003
Figure PCTCN2021071117-appb-000003
从上表可以看出,通过添加纳米二氧化钛,可以提高检测的最低阀值,在培养物浓度为原浓度1/15000时,仍然可以检测到病毒抗原的存在,这说明该物质具有提高检测灵敏度。It can be seen from the above table that the addition of nano-titanium dioxide can increase the minimum detection threshold. When the culture concentration is 1/15000 of the original concentration, the presence of viral antigens can still be detected, which shows that this substance has improved detection sensitivity.
实施例5裂解液配方4Embodiment 5 Lysis solution formula 4
裂解液4含有如下质量分数的组分:0.3mol/L的NaCL,2.9g的Na2HPO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300,0.02%的纳米二氧化钛。所述裂解液的pH为8.0。Lysis solution 4 contains the following components in mass fractions: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.02% nano-titanium dioxide. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本,15分钟后检测T线信号,记录并计算平均值。Use the formula lysate to treat the new coronavirus cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply the sample on the fluorescence immunochromatography detection test paper. After 15 minutes T-line signal was detected, recorded and averaged.
表4配方4的检测结果The detection result of table 4 formula 4
Figure PCTCN2021071117-appb-000004
Figure PCTCN2021071117-appb-000004
实施例6裂解液配方5Embodiment 6 Lysis solution formula 5
裂解液5含有如下质量分数的组分:0.3mol/L的NaCL,2.9g的Na2HPO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300,0.03%的纳米二氧化钛。所述裂解液的pH为8.0。Lysis solution 5 contains the following components in mass fractions: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.03% nano-titanium dioxide. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本,15分钟后检测T线信号,记录并计算平均值。Use the formula lysate to treat the new coronavirus cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply the sample on the fluorescence immunochromatography detection test paper. After 15 minutes T-line signal was detected, recorded and averaged.
表5配方5的检测结果The detection result of table 5 formula 5
Figure PCTCN2021071117-appb-000005
Figure PCTCN2021071117-appb-000005
实施例7裂解液配方6Embodiment 7 Lysis solution formula 6
裂解液6含有如下质量分数的组分:0.3mol/L的NaCL,2.9g的Na2HPO4,0.5%的Casein Na,1%的Triton X-100,0.05%的proclin300,0.05%的纳米二氧化钛。所述裂解液的pH为8.0。Lysis solution 6 contains the following components by mass fraction: 0.3mol/L NaCL, 2.9g Na2HPO4, 0.5% Casein Na, 1% Triton X-100, 0.05% proclin300, 0.05% nano-titanium dioxide. The pH of the lysate was 8.0.
使用该配方裂解液处理浓度分别为1/15000、1/10000、1/5000、1/1000的新型冠状病毒培养物,得到待测样本,在荧光免疫层析检测试纸上施加样本,15分钟后检测T线信号,记录并计算平均值。Use the formula lysate to treat the new coronavirus cultures with concentrations of 1/15000, 1/10000, 1/5000, and 1/1000, respectively, to obtain the sample to be tested, and apply the sample on the fluorescence immunochromatography detection test paper. After 15 minutes T-line signal was detected, recorded and averaged.
表6配方6的检测结果The detection result of table 6 formula 6
Figure PCTCN2021071117-appb-000006
Figure PCTCN2021071117-appb-000006
实施例8Example 8
根据实施例2-7结果,取T线信号平均值对比,统计如表7和图1。可以明显看到配方1和配方2,与配方3至配方6的T线信号平均值的差异,纳米二氧化钛的加入明显提高了检测的灵敏度。According to the results of Examples 2-7, the average value of the T-line signal was compared, and the statistics are shown in Table 7 and FIG. 1 . It can be clearly seen that formula 1 and formula 2, and formula 3 to formula 6, the difference in the average value of the T-line signal, the addition of nano-titanium dioxide significantly improves the detection sensitivity.
表7配方1-6的T线信号平均值汇总表Table 7 Summary table of T-line signal average values for recipes 1-6
培养物浓度/配方Culture concentration/recipe 配方1Recipe 1 配方2Recipe 2 配方3Recipe 3 配方4Recipe 4 配方5Recipe 5 配方6Recipe 6
00 3333 3232 2828 1919 24twenty four 2727
1/150001/15000 3131 3434 154154 179179 169169 163163
1/100001/10000 315315 321321 451451 469469 460460 432432
1/50001/5000 602602 640640 874874 899899 881881 825825
1/10001/1000 27092709 27392739 42144214 43974397 42574257 40754075
本发明说明书中提到的所有专利和出版物都表示这些是本领域的公开技术,本发明可以使用。这里所引用的所有专利和出版物都被同样列在参考文献中,跟每一个出版物具体的单独被参考引用一样。这里所述的本发明可以在缺乏任何一种元素或多种元素,一种限 制或多种限制的情况下实现,这里这种限制没有特别说明。例如这里每一个实例中术语“包含”,“实质由……组成”和“由……组成”可以用两者之一的其余2个术语代替。这里的所谓的“一个”仅仅表示“一”的意思,而不排除仅仅只是包括一个,也可以表示包括2个以上。这里采用的术语和表达方式所为描述方式,而不受其限制,这里也没有任何意图来指明此书描述的这些术语和解释排除了任何等同的特征,但是可以知道,可以在本发明和权利要求的范围内做任何合适的改变或修改。可以理解,本发明所描述的实施例子都是一些优选的实施例子和特点,任何本领域的一般技术人员都可以根据本发明描述的精髓下做一些更改和变化,这些更改和变化也被认为属于本发明的范围和独立权利要求以及附属权利要求所限制的范围内。All patents and publications mentioned in the specification of the present invention indicate that they are disclosed technology in the art and can be used in the present invention. All patents and publications cited herein are also incorporated by reference as if each publication was specifically and individually incorporated by reference. The inventions described herein may be practiced in the absence of any element or elements, limitation or limitations, such limitation not specifically stated herein. For example, the terms "comprising", "consisting essentially of" and "consisting of" in each instance herein may be replaced by either of the remaining two terms. The so-called "one" here only means "one", and it does not exclude that only one is included, and it may also mean that two or more are included. The terms and expressions used herein are by way of description, not limitation, and there is no intention here to indicate that these terms and interpretations described in this book exclude any equivalent features, but it is understood that the present invention and the rights make any suitable changes or modifications to the extent required. It can be understood that the embodiments described in the present invention are all preferred embodiments and features, and any person skilled in the art can make some changes and changes according to the essence of the description of the present invention, and these changes and changes are also considered to belong to The scope of the invention is limited by the independent and dependent claims.

Claims (10)

  1. 一种裂解病毒的试剂,其特征在于,包括二氧化钛、缓冲液、表面活性剂和防腐剂。A reagent for splitting virus, characterized in that it comprises titanium dioxide, buffer solution, surfactant and preservative.
  2. 如权利要求1所述的试剂,其特征在于,所述二氧化钛为纳米二氧化钛。The reagent according to claim 1, wherein the titanium dioxide is nano titanium dioxide.
  3. 如权利要求2所述的试剂,其特征在于,所述纳米二氧化钛的含量为0.01%-0.1%。The reagent according to claim 2, wherein the content of the nano titanium dioxide is 0.01%-0.1%.
  4. 如权利要求3任一项所述的试剂,其特征在于,所述的缓冲液包括氯化钠、磷酸盐和酪蛋白钠。The reagent according to any one of claims 3, wherein the buffer solution comprises sodium chloride, phosphate and sodium caseinate.
  5. 如权利要求4所述的试剂,其特征在于,所述的缓冲液包括氯化钠0.15-0.45mol/L、磷酸盐1.15-2.9g/L、酪蛋白钠的含量为0.5%。The reagent according to claim 4, wherein the buffer solution comprises sodium chloride 0.15-0.45 mol/L, phosphate 1.15-2.9 g/L, and sodium caseinate content of 0.5%.
  6. 如权利要求5所述的试剂,其特征在于,所述表面活性剂为Triton X-100。The reagent of claim 5, wherein the surfactant is Triton X-100.
  7. 如权利要求6所述的试剂,其特征在于,所述防腐剂为Proclin 300。The reagent of claim 6, wherein the preservative is Proclin 300.
  8. 一种荧光免疫层析检测试剂盒,其特征在于,包括如权利要求1~7任一项所述的裂解病毒的试剂,和用于检测病毒抗原的免疫层析试纸。A fluorescence immunochromatography detection kit, characterized in that it comprises the virus splitting reagent according to any one of claims 1 to 7, and an immunochromatographic test paper for detecting virus antigens.
  9. 纳米二氧化钛用于制备裂解病毒样本的试剂上的用途。Use of nano-titanium dioxide for preparing reagents for splitting virus samples.
  10. 如权利要求9所述的用途,其特征在于,所述病毒样本为新型冠状病毒样本。The use according to claim 9, wherein the virus sample is a novel coronavirus sample.
PCT/CN2021/071117 2020-10-29 2021-01-11 Reagent for lysing virus sample WO2022088511A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011178357.0 2020-10-29
CN202011178357.0A CN113281503B (en) 2020-10-29 2020-10-29 Reagent for splitting virus sample

Publications (1)

Publication Number Publication Date
WO2022088511A1 true WO2022088511A1 (en) 2022-05-05

Family

ID=77275297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/071117 WO2022088511A1 (en) 2020-10-29 2021-01-11 Reagent for lysing virus sample

Country Status (2)

Country Link
CN (1) CN113281503B (en)
WO (1) WO2022088511A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114675017A (en) * 2022-03-25 2022-06-28 艾康生物技术(杭州)有限公司 Biological sample extracting solution and application and using method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103968462A (en) * 2014-05-25 2014-08-06 洛阳市睿仕行智能科技发展有限公司 Composite multifunctional device for air activation, dust removal, sterilization and filtering
CN106771218A (en) * 2016-12-06 2017-05-31 河北医科大学生物医学工程中心 A kind of kit of p24 antigens of detection HIV 1 and its application
CN110007095A (en) * 2019-05-06 2019-07-12 江苏硕世生物科技股份有限公司 A kind of dengue virus NS 1 antigen test strip, kit and preparation method thereof
CN110261616A (en) * 2019-04-30 2019-09-20 广东菲鹏生物有限公司 A kind of hepatitis c virus detection reagent box
WO2020037260A1 (en) * 2018-08-17 2020-02-20 Cepheid Methods and compositions for nucleic acid isolation
CN111235311A (en) * 2020-02-28 2020-06-05 天罗诊断科技江苏有限公司 Virus lysis reaction liquid suitable for rapid direct-amplification PCR detection
CN111449318A (en) * 2020-03-18 2020-07-28 同曦集团有限公司 Antibacterial and antiviral mask and preparation method thereof
CN111607635A (en) * 2020-06-23 2020-09-01 大连理工大学 Blood genome DNA extraction method based on 3D printing special-shaped functional body and application kit thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100754399B1 (en) * 2006-04-05 2007-08-31 삼성전자주식회사 Method and apparatus for disrupting cells and purifying nucleic acids using one chamber
CN100582781C (en) * 2006-06-27 2010-01-20 厦门大学 Method for joint investigating hepatitis B virus pro S1 antigen and nuclear antigen and diagnostic kit
JP6734053B2 (en) * 2013-07-25 2020-08-05 古河電気工業株式会社 Immunochromatographic test strip, developing solution used therein, and immunochromatography using the same
CN105606798A (en) * 2016-04-08 2016-05-25 四川新健康成生物股份有限公司 Sample diluent for immunofluorescence chromatography detection
CN110133269A (en) * 2019-05-22 2019-08-16 湖南康润药业股份有限公司 A kind of preparation method and detection card of hepatitis C virus antigen-antibody combined detection reagent
CN111273001A (en) * 2020-02-12 2020-06-12 北京大弘生物技术有限公司 System for rapidly detecting new coronavirus 2019-nCoV in blood sample and preparation method thereof
CN111172239A (en) * 2020-02-28 2020-05-19 上海思路迪医学检验所有限公司 Virus sample preserving fluid, nucleic acid extraction reagent and virus nucleic acid extraction method
CN112680547B (en) * 2020-03-13 2023-07-07 苏州白垩纪生物科技有限公司 Real-time fluorescent nucleic acid isothermal amplification detection kit and application thereof
CN111534570B (en) * 2020-07-07 2020-11-13 上海思路迪医学检验所有限公司 High-throughput mixed sample lytic virus nucleic acid extraction method
CN111718908B (en) * 2020-08-11 2022-05-24 杭州博日科技股份有限公司 Virus sample preserving fluid and preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103968462A (en) * 2014-05-25 2014-08-06 洛阳市睿仕行智能科技发展有限公司 Composite multifunctional device for air activation, dust removal, sterilization and filtering
CN106771218A (en) * 2016-12-06 2017-05-31 河北医科大学生物医学工程中心 A kind of kit of p24 antigens of detection HIV 1 and its application
WO2020037260A1 (en) * 2018-08-17 2020-02-20 Cepheid Methods and compositions for nucleic acid isolation
CN110261616A (en) * 2019-04-30 2019-09-20 广东菲鹏生物有限公司 A kind of hepatitis c virus detection reagent box
CN110007095A (en) * 2019-05-06 2019-07-12 江苏硕世生物科技股份有限公司 A kind of dengue virus NS 1 antigen test strip, kit and preparation method thereof
CN111235311A (en) * 2020-02-28 2020-06-05 天罗诊断科技江苏有限公司 Virus lysis reaction liquid suitable for rapid direct-amplification PCR detection
CN111449318A (en) * 2020-03-18 2020-07-28 同曦集团有限公司 Antibacterial and antiviral mask and preparation method thereof
CN111607635A (en) * 2020-06-23 2020-09-01 大连理工大学 Blood genome DNA extraction method based on 3D printing special-shaped functional body and application kit thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOWARD A. FOSTER; IRAM B. DITTA; SAJNU VARGHESE; ALEX STEELE: "Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, BERLIN, DE, vol. 90, no. 6, 27 April 2011 (2011-04-27), Berlin, DE , pages 1847 - 1868, XP019908978, ISSN: 1432-0614, DOI: 10.1007/s00253-011-3213-7 *
MAZURKOVA N. A., SPITSYNA YU. E., SHIKINA N. V., ISMAGILOV Z. R., ZAGREBEL’NYI S. N., RYABCHIKOVA E. I.: "Interaction of titanium dioxide nanoparticles with influenza virus", NANOTECHNOLOGIES IN RUSSIA, MAIK NAUKA - INTERPERIODICA, RU, vol. 5, no. 5-6, 1 June 2010 (2010-06-01), RU , pages 417 - 420, XP055925083, ISSN: 1995-0780, DOI: 10.1134/S1995078010050174 *

Also Published As

Publication number Publication date
CN113281503B (en) 2022-01-04
CN113281503A (en) 2021-08-20

Similar Documents

Publication Publication Date Title
CN111273001A (en) System for rapidly detecting new coronavirus 2019-nCoV in blood sample and preparation method thereof
CN111983217B (en) Sample treatment fluid and application thereof
CN111198273B (en) Immunoassay kit for anti-phospholipase A2 receptor autoantibody, preparation method and use method thereof
CN103792373A (en) Colloidal gold immunochromatography test paper for antibodies of pseudorabies viruses of gE, gB and gD and preparation method
CN101236201A (en) Method for enhancing detection reagent sensitivity by using colloidal gold or latex granule as marker
US10527618B2 (en) Sample processing method for influenza virus immunoassay, and immunoassay method
CN111537746A (en) Test strip for COVID-19 antigen-antibody combined detection and application thereof
KR20160124905A (en) Immunochromatographic assay method
WO2022088511A1 (en) Reagent for lysing virus sample
WO2015080286A1 (en) Immunochromatography-assisted detection method
TWI639002B (en) Chromatographic medium
CN112305218A (en) Novel coronavirus antibody colloidal gold immune lateral chromatography detection method and application thereof
JP2015210167A (en) Immunochromatographic analyzer, immunochromatographic analysis method, and immunochromatographic analysis kit
Vrublevskaya et al. A sensitive and specific lateral flow assay for rapid detection of antibodies against glycoprotein B of Aujeszky's disease virus
CN111273017B (en) Fluorescent immunochromatography kit for rapidly detecting novel coronaviruses
WO2023284476A1 (en) Novel sars-cov-2 antibody detection test strip
CN109799351A (en) Porcine circovirus 2 type double-antibody sandwich elisa kit and its application
Haines et al. The detection of bovine respiratory syncytial virus in formalin fixed bovine lung with commercially available monoclonal antibodies and avidin biotin complex immunohistochemistry.
CN113391075B (en) Novel coronavirus neutralizing antibody detection test strip and kit
CN109946458A (en) A kind of fluorescent test paper of quick detection Porcine epidemic diarrhea virus and preparation and application
TW202314244A (en) Method of testing feces sample and immunochromatography test strip therefor
Todd et al. Antigenically important proteins of Aujeszky's disease (pseudorabies) virus identified by immunoblotting
CN112114140A (en) Novel coronavirus IgA antibody colloidal gold detection kit
JP6595215B2 (en) Immunochromatographic analyzer, manufacturing method thereof, and immunochromatographic analysis method
Siegesmund et al. A quantitative immunoperoxidase procedure employing energy dispersive x-ray analysis.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21884257

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21884257

Country of ref document: EP

Kind code of ref document: A1